Biotech Stocks Reviews
- Magenta Conditioning Peer Goes Public Via SPAC
Fri, May 7
Yesterday, Magenta (MGTA) competitor Jasper merged with SPAC company Amplitude Healthcare (AMHC). As · more » - Biden’s Covid IP Waiver Is a PR Stunt
Thu, May 6
Yesterday, President Biden backed a proposed waiver for COVID-19 vaccine intellectual property rights. · more » - NovaVax News Flow Expected to Continue
Fri, Apr 30
It has been an eventful week for Novavax (NVAX), and we believe the news flow will spill over into next · more » - Essa Dosing Cohorts Where Optimal Anti-tumor Effects Expected
Thu, Apr 29
Yesterday, Essa (EPIX)announcedanother collaboration, this time with Bayer. The two companies will run a · more » - What to Expect for ASCO21
Thu, Apr 29
The ASCO 2021 meeting is going to be June 4-8. This morning, ASCO 2021 abstracttitleswere released. May · more » - Mono AFM24 Has Some Uncertainty, But Real Potential Is In NK Combo
Thu, Apr 15
Affimed had theirbusiness update callthis morning to primarily discuss updates on AFM24 and a few other · more » - Notes from Affimed’s KOL Call Discussing AACR NK+AFM13
Wed, Apr 14
Affimed(AFMD)hosted a callafter market today to discuss cbNK+AFM13 data presented at AACR. KOL from MD · more » - A Look At Essa & Jounce Preclinical Data at AACR ’21
Mon, Apr 12
A look at pre-clinical data that Jounce and Essa presented at AACR this past weekend. Jounce · more » - Affimed’s AACR Data Validates Bi-Specifics In NK Cell Combinations
Fri, Apr 9
Affimed (AFMD)released initial clinical datafrom the AFM13 + MD Anderson combo study at AACR this · more »